fme AG
fme SRL
fme supports some of the world’s most ambitious acquisition strategies, often under tight timelines, with minimal visibility into the acquired company’s systems, and urgent demands to “make it all work” from day one.
The reality? Most M&A activities start in a rush and stay there. IT and business teams are expected to absorb new entities, migrate content, manage compliance, and sunset legacy platforms, all while trying to maintain continuity and meet regulatory obligations. And they’re expected to do it repeatedly.
Why TransferAssist?
M&A success depends on how quickly and reliably you can bring newly acquired teams, systems, and data into your enterprise technology stack, or, in the case of divestitures, cleanly separate and transfer it. Delays, inconsistencies, or missteps can cost millions in regulatory risk, operational drag, or lost productivity.
fme created TransferAssist to eliminate the friction that typically slows down acquisition and divestiture integration. It delivers a scalable, automation-powered framework that empowers organizations to migrate, separate, or integrate data with speed, confidence, and compliance. Whether you’re evaluating a deal, in the thick of integration, or planning a strategic carve-out, TransferAssist meets you where you are: simplifying, accelerating, and standardizing every step of the process.
The Four-Phase TransferAssist Approach
Whether you’re acquiring three companies a year or ten, TransferAssist helps you shift from project-based chaos to programmatic control. Here’s how:
Phase 1: Foundation & Readiness
This phase establishes your strategic backbone for repeatable M&A success.
- Build a unified, extensible data model and pipeline to receive and integrate new information.
- Define archiving, retention, and migration rules to ensure consistency and compliance.
- Run fme-driven, independent pre-deal assessments to identify data risks and gaps before legal close.
- Leverage standard governance models and prebuilt templates for accelerated onboarding.
★ The bonus? Even before the acquisition is finalized, TransferAssist allows you to evaluate the technical landscape of a target company without exposing sensitive data or compromising confidentiality.
Phase 2: Execution & Automation
Now it’s time to move fast, without sacrificing quality.
- Deploy pre-validated migration playbooks and accelerators to reduce setup time.
- Enable 24/5 global execution coverage via fme teams in North America, Romania, and India.
- Automate classification and verification with AI-powered workflows.
- Monitor and iterate using built-in feedback loops and structured improvement cycles.
★ The result? Faster, more predictable migrations with fewer human errors and more visibility.
Phase 3: User Enablement & Business Continuity
Technology is only half the battle, people and processes matter too.
- Align go-live plans with training and change management strategies.
- Partner with your system integrator to onboard users to the right platforms.
- Reduce dual-system overhead and accelerate decommissioning of legacy tools.
- Measure ROI with KPIs like time-to-productivity, user adoption, and operational savings.
★ Key insight? Happy, empowered users are the fastest path to post-acquisition value.
Phase 4: Optimization & Scalability
Turn repeatability into strategic advantage.
- Transition to a frictionless integration model for future acquisitions.
- Reduce burden on internal IT and business teams.
- Drive continuous improvement with a closed-loop optimization model.
- Seamlessly scale the framework for both large and small acquisition targets.
★ The payoff? You’re not just executing integrations, you’re building a resilient, acquisition-ready enterprise.
Ready to Future-Proof Your Merger & Acquisition Strategy?
If your organization’s growth strategy hinges on acquisitions or divestitures, it’s time to stop improvising. With TransferAssist, fme offers a future-proof, plug-and-play framework to manage the data and content complexities of any M&A&D initiative, before, during, and long after the deal closes.
Whether you’re navigating your first large-scale divestiture or streamlining your tenth acquisition of the year, TransferAssist ensures every transition adds value, not risk.
Download this datasheet to learn more about fme’s TransferAssist.
For even more details on how TransferAssist solves AM&D challenges, be sure to reqest our webinar with TOPRA, The Organization for Professionals in Regulatory Affairs. In this session we discuss the unique regulatory challenges and risks in AM&D initiatives, and how to establish a solid and secure foundation for today and the future.
Webinar 🖥️ Merger-Ready RIM with TransferAssist℠
View the webinar now >>
Authors
David Gwyn, VP Business Consulting Services, fme Life Sciences
David Gwyn is a strategic, creative, and data-driven Business Development and Technology Specialist with extensive expertise in building key partnerships, implementing business strategies, and deploying solutions across the life science and emerging technology industries. For the past 30 years, he has led teams in the delivery of content management, clinical, and quality solutions with a recent focus on end-to-end Regulatory Information Management (RIM). His practice has evolved in parallel to the Life Sciences industry, moving from custom-developed software solutions to packaged-based implementations, and the development of methodologies and best practices to guide practitioners in realizing the greatest return on investment. Mr. Gwyn is passionate about helping organizations evolve from traditional to digital businesses and increase their ability to act with speed and agility.
Meghan Carr, VP Technology Services, fme Life Sciences
With over 18 years of experience in the life sciences industry, Meghan is a proven leader in solving complex IT challenges and delivering effective services and solutions on a global scale. Her experience with firms like Veeva and Sparta System (now Honeywell) has helped Meghan become adept at guiding technology-enabled business across the life sciences industry, from leading pharmaceutical and medical device organizations to nutraceuticals and cosmetics. Her talent at understanding the business goals and process requirements of her clients combined with her vast technology and business experience empower her skill at defining comprehensive solutions that serve today’s needs while preparing for tomorrow’s possibilities.